Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 12-23

  Matysiak, Mariola ^a   Stasiołek, Mariusz ^a   Orłowski, Wojciech ^a   Jurewicz, Anna ^a   Janczar, Szymon ^a   Raine, Cedric S ^b   Selmaj, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Immunomodulation; Indoleamine 2,3 dioxygenase; Stem cells

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN P 15095; INDOLEAMINE 2,3 DIOXYGENASE; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME MECHANISM; FEMALE; IMMUNOMODULATION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; STEM CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11C; APOPTOSIS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY;

EID: 37749045793     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.025     Document Type: Article

References (37)

1. Alhadlaq A., and Mao J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. (2004) 436-448
2. Aune T.M., and Pogue S.L. Inhibition of tumor cell growth by interferon-γ is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J. Clin. Invest. 84 (1989) 863-875.1
3. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., and Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214-2219
4. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
5. Byrne G.I., Lehmann L.K., Kirschbaum J.G., Borden E.C., Lee C.M., and Brown R.R. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interf. Res. 6 (1986) 389-396
6. Chu C.Q., Whittmer S., and Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in IFN-γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192 (2000) 123-128
7. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., and Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 61 (2007) 209-218
8. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis: the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006) 942-955
9. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196 (2002) 459-468
10. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., and Ucelli A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61 (2007) 219-227
11. Gupta S.L., Carlin J.M., Pyati P., Dai W., Pfefferkorn E.R., and Murphy Jr. M.J. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62 (1994) 2277-2284
12. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10711-10716
13. Kucia M., Reca R., Jala V.R., Dawn B., Ratajczak J., and Ratajczak M.Z. Bone marrow as a home of heterogeneous populations of nonhematopoietic stem cells. Leukemia 19 (2005) 1118-1127
14. Lassmann H. Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility. J. Neurol. Sci. 233 (2005) 83-86
15. Liu Y., and Janeway Jr. C. Interferon γ plays a critical role in induced cell death of effector T cells: a possible third mechanism of self-tolerance. J. Exp. Med. 172 (1990) 1735-1739
16. McRae B.L., Vanderlugt C.L., Dal Canto M.C., and Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182 (1995) 75-85
17. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogenic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
18. Mellor A.L., and Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosupression by starvation?. Immunol. Today 20 (1999) 469-473
19. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S., and Goff J.P. Bone marrow as potential source of hepatic oval cells. Science 284 (1999) 1168-1170
20. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
21. Platten M., Ho P.P., Youssef S., Fontoura P., Garren H., Hur E.M., Gupta R., Lee L.Y., Kidd B.A., Robinson W.H., Sobel R.A., Selley M.L., and Steinman L. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310 (2005) 850-855
22. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., and Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 (2003) 688-694
23. Pluchino S., and Martino G. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J. Neurol. Sci. 233 (2005) 117-119
24. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., and Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436 (2005) 266-271
25. Rafaeli Y., Van Parijs L., and Alexander S.I. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196 (2002) 999-1005
26. Seshi B., Kumar S., and Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol. Diseases 26 (2000) 234-246
27. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., and Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196 (2002) 447-457
28. Terness P., Chuang J.-J., and Opelz G. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol. 27 (2006) 68-73
29. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., and Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142 (1989) 1523-1527
30. Vogel W., Grunebach F., Messam C.A., Kanz L., Brugger W., and Buhring H.J. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 88 (2003) 126-133
31. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., and Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1996) 3223-3227
32. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., and Cowden W.B. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery in the target tissue: a possible role for nitric oxide. J. Immunol. 163 (1999) 5278-5386
33. Xiao B.G., Liu X., and Link H. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis. Steroids 69 (2004) 653-659
34. Yu M.., Johnson J.M., and Touhy V.K. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J. Neurosci. Res. 45 (1996) 463-470
35. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., and Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761
36. Zhu W.H., Lu C.Z., Huang Y.M., Link H., and Xiao B.G. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult. Scler. 13 (2007) 33-40
37. Zuba-Surma E.K., Abdel-Latif A., Case J., Tiwari S., Hunt G., Kucia M., Vincent R.J., Ranjan S., Ratajczak M.Z., Srour E.F., Bolli R., and Dawn B. Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. J. Mol. Cell Cardiol. 41 (2006) 650-660